This document provides an overview of current trends in the treatment of schizophrenia. It discusses the causes and symptoms of schizophrenia and describes typical and atypical antipsychotic medications. Recent trends include investigating novel compounds that target additional receptors beyond dopamine, developing partial dopamine agonists, using acetylcholinesterase inhibitors to enhance cognition, employing COX-2 inhibitors to modulate the immune system, and exploring the potential of human stem cells to better understand and treat the disorder.